# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Morgan Stanley initiates coverage on Elevance Health with an Overweight rating and a $643 price target. Elevance Health's d...
Morgan Stanley analyst Erin Wright initiates coverage on Elevance Health (NYSE:ELV) with a Overweight rating and announces P...
- Goldman Sachs Conf
- Goldman Sachs Conf
Cantor Fitzgerald analyst Sarah James reiterates Elevance Health (NYSE:ELV) with a Overweight and maintains $600 price target.